LOS ANGELES, March 4, 2016 /PRNewswire/ -- Redwood Scientific Technologies, Inc. today announced that it has appointed M. Salah Zaki, M.D., as Chief Medical Officer. In this role, Dr. Zaki will oversee scientific research, assist with FDA registration, medical regulation, product development, and global expansion.
"Dr. Zaki brings a vast wealth of medical experience to Redwood during a time when our company is rapidly growing," said Jason Cardiff, President and CEO. "His recruitment as Chief Medical Officer represents our confidence that not only will the company produce incredibly sophisticated products in the future but also that our growth necessitates additional scientific expertise. With the aid of his impressive international experience, Redwood Scientific Technologies will be positioned to expand into foreign markets."
Dr. Zaki joins Redwood from his previous position as the President and CEO of International Medical Consultants. He graduated 6th in his class from the prestigious Al Azhar University Medical School in Cairo, Egypt. As a cardiac surgeon, he has integrated Western medical practices into his work throughout the Middle East. In 2009, he was appointed by the U.S. Embassy in Egypt to be the official medical liaison during President Barack Obama's visit. From 1995-2006, he was Medical Director of the International Department of the Washington Hospital Center. In 1995, Dr. Zaki developed an international patient program to expand the Washington Hospital Center's communications worldwide. In 2001, he was appointed as the first President of the Institute of International Health at the George Washington University Medical Center and also as Medical Director of the International Program at Georgetown University Hospital. He has also served as medical advisor to the Armed Forces of the UAE.
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dr-salah-zaki-appointed-chief-medical-officer-at-redwood-scientific-technologies-inc-300231203.html
SOURCE Redwood Scientific Technologies, Inc.